Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,373 | 1,375 | 98.4% |
| Education | $327.62 | 6 | 1.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $70.41 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $2,762 | 151 | $0 (2024) |
| ABBVIE INC. | $2,096 | 163 | $0 (2024) |
| UCB, Inc. | $1,839 | 102 | $0 (2024) |
| Biogen, Inc. | $1,653 | 75 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,298 | 114 | $0 (2024) |
| Eisai Inc. | $1,148 | 65 | $0 (2024) |
| EMD Serono, Inc. | $844.82 | 40 | $0 (2024) |
| PFIZER INC. | $639.63 | 32 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $611.15 | 39 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $607.55 | 32 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,712 | 238 | ABBVIE INC. ($428.89) |
| 2023 | $4,281 | 225 | AbbVie Inc. ($529.44) |
| 2022 | $4,310 | 250 | ABBVIE INC. ($656.99) |
| 2021 | $3,458 | 223 | AbbVie Inc. ($480.81) |
| 2020 | $2,354 | 139 | Teva Pharmaceuticals USA, Inc. ($361.72) |
| 2019 | $2,021 | 107 | Alexion Pharmaceuticals, Inc. ($256.59) |
| 2018 | $1,770 | 99 | Teva Pharmaceuticals USA, Inc. ($312.18) |
| 2017 | $1,866 | 104 | Avanir Pharmaceuticals, Inc. ($300.97) |
All Payment Transactions
1,385 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $32.23 | General |
| Category: Neurology | ||||||
| 12/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $34.66 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/16/2024 | Biogen, Inc. | AVONEX (Biological), VUMERITY | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Neurology | ||||||
| 12/13/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Central Nervous System | ||||||
| 12/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $3.05 | General |
| Category: Central Nervous System | ||||||
| 12/10/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: EPILEPSY | ||||||
| 12/10/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.32 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: Neurology | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: PAIN | ||||||
| 12/03/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $31.89 | General |
| Category: Neurology | ||||||
| 11/27/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $39.85 | General |
| Category: Central Nervous System | ||||||
| 11/20/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $4.01 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: EPILEPSY | ||||||
| 11/18/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/14/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/08/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $6.92 | General |
| Category: Neurology | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $2.87 | General |
| Category: Neurology | ||||||
| 11/04/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Immunology and Neurology | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $3.08 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,104 | 1,814 | $590,656 | $195,474 |
| 2022 | 16 | 1,384 | 2,149 | $648,705 | $230,347 |
| 2021 | 14 | 1,344 | 2,285 | $732,348 | $240,677 |
| 2020 | 14 | 1,181 | 1,922 | $545,622 | $165,198 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 306 | 721 | $136,795 | $68,329 | 50.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 54 | 58 | $33,350 | $21,864 | 65.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 103 | 255 | $38,250 | $20,457 | 53.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 100 | 100 | $35,990 | $17,524 | 48.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 69 | 72 | $108,000 | $12,822 | 11.9% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 29 | 61 | $42,700 | $10,337 | 24.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 63 | 68 | $18,700 | $8,279 | 44.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 36 | 37 | $66,600 | $7,720 | 11.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 143 | 152 | $25,840 | $6,842 | 26.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 93 | $13,206 | $6,104 | 46.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 46 | 46 | $13,050 | $4,974 | 38.1% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 23 | 25 | $7,900 | $2,739 | 34.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 21 | 59 | $8,850 | $2,100 | 23.7% |
| 95912 | Nerve conduction, 11-12 studies | Facility | 2023 | 17 | 17 | $30,600 | $2,071 | 6.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 21 | 21 | $5,055 | $1,457 | 28.8% |
| 95717 | Measurement of brain wave activity (eeg), 2-12 hours with health care professional review and report | Facility | 2023 | 14 | 15 | $3,750 | $1,247 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 14 | $2,020 | $606.48 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 294 | 562 | $105,015 | $53,637 | 51.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 133 | 166 | $45,105 | $24,892 | 55.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 129 | 129 | $45,950 | $22,567 | 49.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 99 | 230 | $34,500 | $19,157 | 55.5% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 47 | 48 | $27,600 | $18,841 | 68.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 104 | 238 | $33,796 | $14,267 | 42.2% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 70 | 72 | $108,000 | $13,322 | 12.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 119 | $18,683 | $10,208 | 54.6% |
About Dr. Harjit Bajaj, M.D
Dr. Harjit Bajaj, M.D is a Specialist healthcare provider based in Glen Burnie, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811977051.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harjit Bajaj, M.D has received a total of $24,771 in payments from pharmaceutical and medical device companies, with $4,712 received in 2024. These payments were reported across 1,385 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($24,373).
As a Medicare-enrolled provider, Bajaj has provided services to 5,013 Medicare beneficiaries, totaling 8,170 services with total Medicare billing of $831,696. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Glen Burnie, MD
- Active Since 01/21/2006
- Last Updated 07/21/2022
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1811977051
Products in Payments
- UBRELVY (Drug) $1,796
- Briviact (Drug) $1,254
- KESIMPTA (Drug) $980.27
- NURTEC ODT (Drug) $948.82
- AUSTEDO (Drug) $934.22
- APTIOM (Drug) $934.00
- Fycompa (Drug) $882.77
- ACTHAR (Biological) $620.54
- VALTOCO (Drug) $603.67
- Austedo XR (Drug) $573.35
- ZEPOSIA (Drug) $565.47
- AJOVY (Biological) $540.13
- BAFIERTAM (Drug) $535.26
- Ponvory (Drug) $421.83
- QULIPTA (Drug) $417.92
- NUEDEXTA (Drug) $381.19
- AUBAGIO (Drug) $372.90
- VYEPTI (Biological) $365.14
- NUPLAZID (Drug) $336.81
- ADUHELM (Biological) $330.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Glen Burnie
Dr. Zvezdomir Zamfirov, M.d, M.D
Specialist — Payments: $22,718
Dr. Marjorie Gwynn, Md, MD
Specialist — Payments: $8,462
Dr. Harvey Brilliant, Md, MD
Specialist — Payments: $6,378
Mr. James Murphy, M.d, M.D
Specialist — Payments: $3,517
Dr. Arnold Kirshenbaum, M.d, M.D
Specialist — Payments: $2,218
Robin Ulanow, Md, MD
Specialist — Payments: $1,870